Back
World News

Global Underreporting of Long COVID Persists Due to Diagnostic Challenges, Healthcare Gaps, and Stigma

Generated on: Last updated: 1 sources
View source

The Unseen Burden: The Global Underreporting of Long COVID

A significant gap exists between the estimated global prevalence of Long COVID and official diagnosis rates, with underreporting particularly acute in low- and middle-income countries. Research indicates systemic barriers, diagnostic complexity, and social stigma prevent many cases from being formally recognized, complicating public health responses and patient care.

Evidence of Underreporting

Multiple studies highlight a disparity between estimated and diagnosed cases of Long COVID, a condition characterized by persistent symptoms following COVID-19 infection.

  • A 2025 study of 1.8 million London residents found only 0.33% had a Long COVID diagnosis recorded in primary care records. This contrasts with previous U.K. government estimates suggesting approximately 3% of the population was affected.
  • A separate 2025 paper estimated that 36% of people with confirmed COVID-19 cases globally have experienced Long COVID. The authors noted significant uncertainty in this figure, especially in regions like Africa where few studies have been conducted.
  • A 2026 research review suggested that limited medical resources, low awareness among healthcare providers, and socioeconomic barriers cause many Long COVID cases to go unreported in LMICs.

Only 0.33% of 1.8 million London residents had a Long COVID diagnosis in primary care records, starkly contrasting with a 3% population prevalence estimate.

Factors Contributing to Underreporting

Underreporting stems from a combination of healthcare system limitations, diagnostic challenges, and patient-level barriers.

Healthcare System and Resource Limitations

  • Many regions, particularly LMICs, face limited medical and public health resources.
  • A lack of clear guidance from some governments and public health authorities has been cited as a factor.
  • Low awareness of Long COVID among healthcare providers can lead to missed diagnoses.

Diagnostic Complexity

  • Long COVID is not a single illness but a disease state associated with over 200 documented symptoms affecting multiple organ systems.
  • There is no single diagnostic test for the condition. Major clinical guidelines do not require one, and the varied symptom presentations pose challenges for clinicians.

Social, Cultural, and Economic Barriers

  • Stigma, cultural norms, and socioeconomic factors discourage some individuals from seeking care or reporting symptoms.
  • Studies indicate people in wealthier countries are more likely to report chronic post-COVID symptoms than those in LMICs.
  • Specific obstacles identified in research include:
    • Kenya: A 2025 study found some people hesitate to seek Long COVID care due to concerns about being mistaken for having HIV.
    • India: A 2025 report concluded that fears of jeopardizing careers, marriage prospects, or social standing prevent some from seeking care.
    • South Africa: Advocates describe a fear of the financial and social consequences of a chronic illness diagnosis, with cultural expectations discouraging some, particularly men, from acknowledging illness.

Geographic Variations in Symptom Reporting

Research indicates that commonly reported Long COVID symptoms may vary by region, though the reasons are not fully understood and may involve both biological and reporting factors.

  • The LC-Optimize trial found cognitive dysfunction and fatigue were the most common symptom cluster reported in the U.S., while muscle and joint pain were most common in Brazil, and dizziness, headache, and joint pain were most common in Zambia.
  • An international study published in Frontiers in Human Neuroscience reported 86% of participants in the U.S. reported cognitive dysfunction, compared to roughly 62% in Colombia and Nigeria and about 15% in India.
  • Study author Igor Koralnik suggested that in countries with fewer healthcare providers and stronger stigmas around mental health, people may not realize cognitive symptoms are related to COVID-19 or may choose not to discuss them.
  • A commentary on that study noted methodological limitations, such as varying familiarity with symptom terminology like "brain fog," may have influenced the reported differences.

In countries with fewer healthcare providers and stronger stigmas around mental health, people may not realize cognitive symptoms are related to COVID-19 or may choose not to discuss them.

Efforts to Improve Awareness and Diagnosis

Researchers, advocates, and health organizations are implementing initiatives to address underreporting.

  • Public Awareness: The World Health Organization's European office published a campaign in early 2026 to dispel myths about Long COVID.
  • Patient Tools: Professor Nisreen Alwan of the University of Southampton and colleagues developed a free online evaluation tool to help individuals determine if health problems could be related to Long COVID and to provide guidance for discussing it with healthcare providers.
  • Provider Education: Project ECHO, in partnership with the nonprofit Schmidt Initiative for Long COVID (SILC), offers multilingual webinars to help healthcare providers, particularly in LMICs, learn about Long COVID diagnosis and management.

Advocate Perspectives

Patient advocates have described personal challenges in obtaining recognition and care for Long COVID.

  • Sourya Sidhhartha Dash, an advocate in India: "Even today in India, doctors do not recognize or want to talk about Long COVID." He stated it took 18 months of self-advocacy to receive a diagnosis after initially being dismissed by doctors.
  • Mlindeni Gabela, an advocate in South Africa: He said some people with symptoms avoid accepting a diagnosis due to financial concerns and fear of dismissal within the healthcare system, adding, "Everyone is so scared to be sick like me."